Non-cardiomyocyte microRNAs in heart failure
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the heart, miRNAs are involved both in cardiogenesis (14, 15) and in disease including: diabetic cardiomyopathy, hypertrophy, ischemia, and electrical remodeling (16-22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866 · cited 1×
“miR-155 is abundantly expressed in monocytes, T-cells, and B-cells, where it is induced upon exposure to a variety of inflammatory cytokines.(79) miR-155 is considered a pro-inflammatory miRNA, as was evidenced by the miR-155 knockout mice.”
BackgroundRequirement of bic/microRNA-155 for Normal Immune Function
Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., et al. (2007) · Science · doi:10.1126/science.1139253 · Cited by 1,833 · cited 1×
“miR-155 is considered a pro-inflammatory miRNA, as was evidenced by the miR-155 knockout mice.(80) These mice are immunodeficient and highly resistant to experimentally induced auto-”
BackgroundLNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 1×
“On the other hand, antimiRs seem to inhibit miRNA activity by the formation of a very stable complex with the mature miRNA, visualized by a slower migrating complex on northern blot assays.(20,21) Secondly, despite effective binding of the miRNA by both antagomirs and antimiRs, the LNA-modified antimiRs have been show…”
BackgroundPhylogenetic Shadowing and Computational Identification of Human microRNA Genes
Berezikov, E., Guryev, V., van de Belt, J., Wienholds, E., Plasterk, R. H. A., & Cuppen, E. (2005) · Cell · doi:10.1016/j.cell.2004.12.031 · Cited by 1,270 · cited 1×
“In the human genome, the estimated number of miRNAs is as high as 1000, and their predicted target genes are involved in virtually every biological process.(4) Early evidence that miRNAs are”
BackgroundmiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
Liu, G., Friggeri, A., Yang, Y., Milosevic, J., Ding, Q., Thannickal, V. J., Kaminski, N., & Abraham, E. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100035 · Cited by 935
Fasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M. C., & Martelli, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800731200 · Cited by 912
Brutsaert, D. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00017.2002 · Cited by 697 · cited 1×
“Besides their apparent role in blood supply and angiogenesis, ECs of the heart release a variety of factors, such as nitric oxide (NO), endothelin, prostaglandins, and angiotensin II, which directly influence cardiac metabolism, growth, and contractile performance of the heart.(40)”
BackgroundDong, S., Cheng, Y., Yang, J., Li, J., Liu, X., Wang, X., Wang, D., Krall, T. J., Delphin, E. S., & Zhang, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027896 · Cited by 454 · cited 3×
“On the contrary, overexpression of miR-21 (using aMHC transgenic mice or adenovirus in rat) protected against cardiac ischaemic injury by a reduction in apoptosis.(29,30) Interestingly, TAC surgery in these aMHC-miR-21-transgenic mice did not reveal a function in cardiomyocyte hypertrophy,(9) suggesting”
BackgroundMethod
Research works printed but not linked: 75
- Creemers, 2011, Nature reviews. Genetics, 12, 357, 10.1038/nrg2983 · DOI
- Souders, 2009, Circulation Research, 105, 1164, 10.1161/CIRCRESAHA.109.209809 · DOI · Paper page
- Bartel, 2004, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
- 2007, Physiological Genomics, 31, 365, 10.1152/physiolgenomics.00206.2007 · DOI
- 2008, PNAS, 105, 2111, 10.1073/pnas.0710228105 · DOI · Paper page
- 2008, Circulation, 118, 1567, 10.1161/CIRCULATIONAHA.108.769984 · DOI · Paper page
- Care, 2007, Nature medicine, 13, 613, 10.1038/nm1582 · DOI · Paper page
- Wang, 2008, Developmental cell, 15, 261, 10.1016/j.devcel.2008.07.002 · DOI · Paper page
- 2011, Cardiovascular Research, 89, 265, 10.1093/cvr/cvq308 · DOI · Paper page
- 2011, Cardiovascular Research, 89, 744, 10.1093/cvr/cvq329 · DOI · Paper page
- 2010, Cardiovascular Research, 87, 431, 10.1093/cvr/cvq082 · DOI · Paper page
- Davis, 2008, Nature; Physical Science (London), 454, 56, 10.1038/nature07086 · DOI · Paper page
- 2007, Circulation Research, 100, 1164, 10.1161/01.RES.0000265065.26744.17 · DOI · Paper page
- 2006, PNAS, 103, 18255, 10.1073/pnas.0608791103 · DOI · Paper page
- Davis, 2010, Molecular cell, 39, 373, 10.1016/j.molcel.2010.07.011 · DOI · Paper page
- van Rooij, 2011, Circulation Research, 108, 219, 10.1161/CIRCRESAHA.110.227496 · DOI · Paper page
- Kr tzfeldt, 2005, Nature; Physical Science (London), 438, 685, 10.1038/nature04303 · DOI · Paper page
- Patrick, 2010, Journal of Clinical Investigation, 120, 3912, 10.1172/JCI43604 · DOI · Paper page
- 2009, Cardiovascular Research, 82, 21, 10.1093/cvr/cvp015 · DOI · Paper page
- 2011, American Journal of Physiology - Renal Physiology, 301, F793, 10.1152/ajprenal.00273.2011 · DOI · Paper page
- 2011, Journal of the American Society of Nephrology, 22, 1668, 10.1681/ASN.2010111168 · DOI · Paper page
- 2011, PNAS, 108, 10144, 10.1073/pnas.1103735108 · DOI · Paper page
- Thum, 2011, Journal of Clinical Investigation, 121, 461, 10.1172/JCI45938 · DOI
- Obad, 2011, Nature genetics, 43, 371, 10.1038/ng.786 · DOI · Paper page
- 2010, Journal of Biological Chemistry, 285, 20281, 10.1074/jbc.M110.109207 · DOI · Paper page
- 2008, PNAS, 105, 13027, 10.1073/pnas.0805038105 · DOI · Paper page
- Park, 2009, Nature structural & molecular biology, 16, 23, 10.1038/nsmb.1533 · DOI · Paper page
- 2011, Journal of Biological Chemistry, 286, 11837, 10.1074/jbc.M110.194969 · DOI · Paper page
- 2010, Hypertension, 55, 946, 10.1161/HYPERTENSIONAHA.109.139519 · DOI
- 2010, American Journal of Physiology - Heart and Circulatory Physiology, 298, H1340, 10.1152/ajpheart.00592.2009 · DOI
- 2008, Genes & Development, 22, 3242, 10.1101/gad.1738708 · DOI · Paper page
- 2009, Circulation Research, 104, 170, 10.1161/CIRCRESAHA.108.182535 · DOI · Paper page
- 2009, Cardiovascular Research, 83, 465, 10.1093/cvr/cvp130 · DOI · Paper page
- 2010, Circulation Research, 106, 166, 10.1161/CIRCRESAHA.109.202176 · DOI · Paper page
- Boak, 2004, Current vascular pharmacology, 2, 45, 10.2174/1570161043476546 · DOI
- MacCarthy, 2000, Circulation, 101, 1854, 10.1161/01.CIR.101.15.1854 · DOI
- 2008, Circulation, 118, 818, 10.1161/CIRCULATIONAHA.107.717702 · DOI · Paper page
- De Boer, 2003, Microcirculation (New York, N.Y. : 1994), 10, 113, 10.1038/sj.mn.7800188 · doi:10.1038/sj.mn.7800188 · Paper page
- 2006, Hypertension, 47, 887, 10.1161/01.HYP.0000215207.54689.31 · DOI · Paper page
- 2001, PNAS, 98, 5780, 10.1073/pnas.091415198 · DOI · Paper page
- 2007, Circulation Research, 101, 59, 10.1161/CIRCRESAHA.107.153916 · DOI · Paper page
- Wang, 2009, Current opinion in genetics & development, 19, 205, 10.1016/j.gde.2009.04.002 · DOI · Paper page
- Fish, 2008, Developmental cell, 15, 272, 10.1016/j.devcel.2008.07.008 · DOI · Paper page
- 2011, Circulation Research, 108, 201, 10.1161/CIRCRESAHA.110.225045 · DOI
- 2009, Science, 324, 1710, 10.1126/science.1174381 · DOI · Paper page
- 2010, Blood, 115, 4944, 10.1182/blood-2010-01-264812 · DOI · Paper page
- Dews, 2006, Nature genetics, 38, 1060, 10.1038/ng1855 · DOI · Paper page
- van Almen, 2011, Aging cell, 10, 769, 10.1111/j.1474-9726.2011.00714.x · DOI · Paper page
- Ventura, 2008, Cell, 132, 875, 10.1016/j.cell.2008.02.019 · DOI · Paper page
- Sabatel, 2011, 6, e16979, 10.1371/journal.pone.0016979 · DOI · Paper page
- Sabatel, 2010, Molecular cancer [electronic resource], 9, 231, 10.1186/1476-4598-9-231 · DOI
- 2010, Circulation Research, 107, 138, 10.1161/CIRCRESAHA.110.216770 · DOI · Paper page
- 2011, PNAS, 108, 8287, 10.1073/pnas.1105254108 · DOI · Paper page
- 2011, Circulation, 124, 720, 10.1161/CIRCULATIONAHA.111.039008 · DOI · Paper page
- 2011, Journal of Experimental Medicine, 208, 549, 10.1084/jem.20101547 · DOI · Paper page
- Ivan, 2008, Journal of cellular and molecular medicine, 12, 1426, 10.1111/j.1582-4934.2008.00398.x · DOI · Paper page
- Hu, 2010, Circulation, 122, S124, 10.1161/CIRCULATIONAHA.109.928424 · DOI · Paper page
- 2009, Journal of Biological Chemistry, 284, 33161, 10.1074/jbc.M109.020925 · DOI · Paper page
- 2010, Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 1562, 10.1161/ATVBAHA.110.206201 · DOI · Paper page
- 2010, Molecular and Cellular Biology, 30, 3902, 10.1128/MCB.01237-09 · DOI
- 2010, Circulation Research, 107, 1336, 10.1161/CIRCRESAHA.110.227926 · DOI · Paper page
- 2011, Circulation, 123, 999, 10.1161/CIRCULATIONAHA.110.000323 · DOI · Paper page
- Sucharov, 2008, Journal of molecular and cellular cardiology, 45, 185, 10.1016/j.yjmcc.2008.04.014 · DOI · Paper page
- Devaux, 1997, European Heart Journal, 18, 470, 10.1093/oxfordjournals.eurheartj.a015268 · DOI · Paper page
- Testa, 1996, Journal of the American College of Cardiology, 28, 964, 10.1016/S0735-1097(96)00268-9 · DOI · Paper page
- Seta, 1996, Journal of cardiac failure, 2, 243, 10.1016/S1071-9164(96)80047-9 · DOI · Paper page
- Ha, 2011, Antioxidants & redox signaling, 15, 1875, 10.1089/ars.2010.3723 · DOI
- 2007, American Journal Of Pathology, 170, 1831, 10.2353/ajpath.2007.061170 · DOI · Paper page
- 2011, Journal of Molecular Cell Biology, 3, 159, 10.1093/jmcb/mjr007 · DOI · Paper page
- 2010, Cardiovascular Research, 87, 656, 10.1093/cvr/cvq148 · DOI · Paper page
- 2007, Journal of Biological Chemistry, 282, 24262, 10.1074/jbc.M701050200 · DOI · Paper page
- Sheedy, 2010, Nature immunology, 11, 141, 10.1038/ni.1828 · DOI · Paper page
- Zernecke, 2009, Science Signaling, 2, ra81, 10.1126/scisignal.2000610 · DOI · Paper page
- 2010, Circulation Research, 106, 1035, 10.1161/CIRCRESAHA.110.218297 · DOI · Paper page
- 2010, Science, 327, 198, 10.1126/science.1178178 · DOI · Paper page
Cited by
Exosome Processing and Characterization Approaches for Research and Technology Development
Lai, J. J., Chau, Z. L., Chen, S., Hill, J. J., Korpany, K. V., Liang, N., Lin, L., Lin, Y., Liu, J. K., Liu, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202103222 · Cited by 623
MicroRNAs in Heart Failure: From Biomarker to Target for Therapy
Vegter, E. L., van der Meer, P., de Windt, L. J., Pinto, Y. M., & Voors, A. A. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.495 · Cited by 303
Self-citationMicroRNA29: A Mechanistic Contributor and Potential Biomarker in Atrial Fibrillation
Dawson, K., Wakili, R., Ördög, B., Clauss, S., Chen, Y., Iwasaki, Y., Voigt, N., Qi, X. Y., Sinner, M. F., Dobrev, D., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.001207 · Cited by 252
Soller, K. J., Yang, J., Veglia, G., & Bowser, M. T. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738807 · Cited by 20
Metadata
- Authors
- Tijsen, A. J., Pinto, Y. M., & Creemers, E. E.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-12-16
- Volume
- 93
- Issue
- 4
- Pages
- 573-582
- ISSN
- 0008-6363
- Cited by
- 89
- References
- 10
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non-cardiomyocyte microRNAs in heart failure. https://app.cochat.ai/papers/10.1093/cvr/cvr344
- The paper
- Tijsen, A. J., Pinto, Y. M., & Creemers, E. E. (2012). Non-cardiomyocyte microRNAs in heart failure. Cardiovascular Research. https://doi.org/10.1093/cvr/cvr344
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.